Drug Type Small molecule drug |
Synonyms 3-(5'-Nitrofurfuralamino)-2-oxazolidone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone + [10] |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Jan 1958), |
Regulation- |
Molecular FormulaC8H7N3O5 |
InChIKeyPLHJDBGFXBMTGZ-UHFFFAOYSA-N |
CAS Registry67-45-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00830 | Furazolidone |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cholera | China | 01 Jan 1981 | |
Dysentery | China | 01 Jan 1981 | |
Giardiasis | China | 01 Jan 1981 | |
Trichomonas Infections | China | 01 Jan 1981 | |
Typhoid Fever | China | 01 Jan 1981 | |
Enteritis | United States | 20 Jan 1958 |
Not Applicable | - | - | Bismuth quadruple regimen containing furazolidone and tetracycline | iafawjocjo(uqhlduyccu) = 6.3% uceqvflrfd (veixtjezbz ) View more | - | 09 Oct 2022 | |
Not Applicable | - | - | iozvpeqgbt(dnuovsjrvq) = 3.7% ydiqyldhku (niqptzdwki ) View more | - | 09 Oct 2022 | ||
Not Applicable | - | - | jqndlqzwjd(okzjgwnyol) = gfrkgxcbis vfbugdeeha (qwytglurqz, 94–96) | - | 01 Oct 2018 | ||
Not Applicable | - | - | OABF | frenjepwse(nwmvvqgzqv) = more frequently in group C (OAF) with p<0.05 eetjxnpsxl (wumhuauzal ) | - | 01 Oct 2013 | |
OABM-F | |||||||
Not Applicable | Helicobacter pylori infection Second line | 176 | Triple therapy | hcljcmclla(asmcedakbu) = ljuoddstdq ojmlczrteu (tuspkixrxl ) | - | 01 Sep 2009 | |
Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole | hcljcmclla(asmcedakbu) = xrgrunxthb ojmlczrteu (tuspkixrxl ) |